Articles with public access mandates - Shereen EzzatLearn more
Not available anywhere: 6
Acromegaly: re-thinking the cancer risk
S Loeper, S Ezzat
Reviews in Endocrine and Metabolic Disorders 9, 41-58, 2008
Mandates: Canadian Institutes of Health Research, German Research Foundation
Chromatin remodeling and histone modifications in pituitary tumors
T Tateno, X Zhu, SL Asa, S Ezzat
Molecular and Cellular Endocrinology 326 (1-2), 66-70, 2010
Mandates: Canadian Institutes of Health Research
The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary
Z Shen, SL Asa, S Ezzat
Molecular and Cellular Endocrinology 461, 188-193, 2018
Mandates: Canadian Institutes of Health Research
FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome
R Hofstedter, MC Sanabria-Salas, M Di Jiang, S Ezzat, O Mete, RH Kim
Endocrine Pathology 34 (2), 257-264, 2023
Mandates: Ontario Institute for Cancer Research
Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell function
Z Shen, SL Asa, S Ezzat
Molecular and cellular endocrinology 439, 126-132, 2017
Mandates: Canadian Institutes of Health Research
Response to Miyauchi et al. re: “A Prospective Mixed-Methods Study of Decision Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer”
AM Sawka, NN Baxter, A Gafni, S Ezzat, DP Goldstein, ...
Thyroid 30 (10), 1542-1543, 2020
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research
Available somewhere: 46
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis
AM Sawka, L Thabane, L Parlea, I Ibrahim-Zada, RW Tsang, JD Brierley, ...
Thyroid 19 (5), 451-457, 2009
Mandates: Canadian Institutes of Health Research
Biomarkers of aggressive pituitary adenomas
O Mete, S Ezzat, SL Asa
Journal of molecular endocrinology 49 (2), R69-R78, 2012
Mandates: Canadian Institutes of Health Research
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
MJ Alvarez, PS Subramaniam, LH Tang, A Grunn, M Aburi, G Rieckhof, ...
Nature genetics 50 (7), 979-989, 2018
Mandates: US National Institutes of Health
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
AM Sawka, DC Lakra, J Lea, B Alshehri, RW Tsang, JD Brierley, S Straus, ...
Clinical endocrinology 69 (3), 479-490, 2008
Mandates: Canadian Institutes of Health Research
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis
W Liu, S Cheng, SL Asa, S Ezzat
Cancer research 68 (19), 8104-8112, 2008
Mandates: Canadian Institutes of Health Research
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation
CD Simpson, IA Mawji, K Anyiwe, MA Williams, X Wang, AL Venugopal, ...
Cancer research 69 (7), 2739-2747, 2009
Mandates: Canadian Institutes of Health Research, Ontario Institute for Cancer Research
Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review
AM Sawka, I Ibrahim-Zada, P Galacgac, RW Tsang, JD Brierley, S Ezzat, ...
Thyroid 20 (10), 1129-1138, 2010
Mandates: Canadian Institutes of Health Research
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study
AM Sawka, DP Goldstein, JD Brierley, RW Tsang, L Rotstein, S Ezzat, ...
PloS one 4 (1), e4191, 2009
Mandates: Canadian Institutes of Health Research
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia
X Zhu, SL Asa, S Ezzat
Clinical Cancer Research 14 (7), 1984-1996, 2008
Mandates: Canadian Institutes of Health Research
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors
AM Sawka, J Lea, B Alshehri, S Straus, RW Tsang, JD Brierley, ...
Clinical endocrinology 68 (4), 610-617, 2008
Mandates: Canadian Institutes of Health Research
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis
T Tateno, SL Asa, L Zheng, T Mayr, A Ullrich, S Ezzat
PLoS genetics 7 (12), e1002400, 2011
Mandates: Canadian Institutes of Health Research
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function
RB Zavareh, KS Lau, R Hurren, A Datti, DJ Ashline, M Gronda, P Cheung, ...
Cancer research 68 (16), 6688-6697, 2008
Mandates: Canadian Institutes of Health Research
Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas
O Mete, AS Tischler, R De Krijger, AM McNicol, G Eisenhofer, K Pacak, ...
Archives of Pathology and Laboratory Medicine 138 (2), 182-188, 2014
Mandates: US National Institutes of Health
A prospective mixed-methods study of decision-making on surgery or active surveillance for low-risk papillary thyroid cancer
AM Sawka, S Ghai, T Yoannidis, L Rotstein, PJ Gullane, RW Gilbert, ...
Thyroid 30 (7), 999-1007, 2020
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program